Jun Qu
Professor @ University at Buffalo
Buffalo, United States
Jun Qu is a startup investor at University at Buffalo in Buffalo. Dr. Qu is an Associate Professor in the Pharmaceutical Sciences Department of SUNY-Buffalo. His interests are in Proteomics and Pharmaceutical Analysis, and their applications in pharmaceutical and clinical research. His research programs in the proteomic field involve i) high-resolution and large-scale expression profiling of pathologicalproteomes (e.g. for cardiovascular diseases, colon cancer and infectious diseases, HIV, COPD, etc) for the discovery of disease/drug-effect biomarkers by gel-free LC/MS methods; ii) Sensitive identification, localization and quantification of post-translational modifications in complex proteomes, with the emphases on arginine methylation and phosphorylation. Novel anti-PTM-peptides capture procedure and alternating collision induced dissociation (CID)/electron transferring dissociation (ETD) are employed to obtain abundant PTM information; iii) targeted quantification of protein drugs and biomarkers for clinical study. Dr. Qu’s lab possesses many state-of-the-art LC/MS instruments, including a high resolution/accuracy LTQ/Orbitrap ELITE with ETD, a highly sensitive TSQ Quantum Ultra EMR triple-quadrupole instrument, ultra-high pressure nano-LC systems, and HPLC instruments for pre-fraction and ion chromatography. A number of key analytical advances have been developed by his lab that greatly enhanced the drug discovery and development processes. He has been actively collaborating with Kinex since 2010 using cutting-edge proteomics and LC/MS techniques for in-depth investigation of the mechanisms of actions of Kinex compounds.
Last updated:
For AI agents: llms.txt
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
About University at Buffalo
Although the State University of New York system boasts a number of impressive colleges, none are as comprehensive as the University at Buffalo (UB). With nearly 30,000 students, the University at Buffalo is the largest of the SUNYs, yet it maintains a low student-to-faculty ratio under 13:1.UB’s academics are divided amongst more than a dozenschools and colleges. About 100 undergraduate degrees are available, as well as nearly 300 master’s, doctoral and professional degrees. This staggering variety of academics is enough to satisfy even the most intellectually curious of students.Student life at UB features a number of ways to get involved, including service programs, student organizations, and Greek life. The university also organizes several cultural events throughout the year, such as concerts and guest speakers.The typical University at Buffalo financial aid packages is consist of a federal grant and loan, a campus job and an institutional scholarship. UB’s scholarships are based on merit and can be renewed for up to four years.Admissions to UB are competitive, and the university recommends rigorous college prep coursework in high school. Your academic record is the main consideration, but UB’s admissions officers also consider a variety of criteria, such as community service, creative ability, and leadership.
University at Buffalo Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Adel Sadek
Acting Chair
|
|||
Arun Vishwanath
Associate Professor
|
|||
David Thiemecke
Startup Ventures Team
|
|||
|
Jun Qu
Professor
|
|||
Norma J. Nowak
Professor
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
How do I contact Jun Qu?
Public channels for Jun Qu include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
